Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients
Status:
Terminated
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
Prospective, randomized, placebo controlled, phase II clinical study of subjects crossing
over from an approved inhaled antibiotic to inhaled nitric oxide as compared to a placebo
control arm.
Phase:
Phase 2
Details
Lead Sponsor:
Novoteris, LLC
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics Mallinckrodt